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ABSTRACT
Dengue is endemic in more than 100 countries in Southeast Asia, the Americas, the western Pacific, Africa and the eastern 
Mediterranean regions. The virus is transmitted by Aedes mosquitoes. Dengue disease is the most prevalent arthropod-
borne viral disease in humans and is a global and national public health concern in several countries. A seasonal pattern 
of dengue disease is consistently observed. The highest incidences usually correspond to the period of highest rainfall 
and humidity, providing suitable conditions for Aedes aegypti breeding and survival. In Brazil for instance it is from 
January to June. Dengue may cause marked changes in bone marrow that result in hypocellularity and, consequently, 
thrombocytopenia and leucopenia, along with an increase in hematocrit, which is secondary to capillary leakage. 
However, those abnormalities are usually self-limited, and do not warrant further investigations, such as a marrow 
biopsy or a myelogram. The occurrence of persistent reactive hemophagocytosis is uncommon and usually leads to 
serious adverse outcomes. The authors report the case of an 8-year old girl complaining of high-grade fever, malaise, 
headache, abdominal pain and a cutaneous rash. Laboratory examination revealed atypical lymphocytosis on peripheral 
blood count, hyperbilirrunemia, abnormal liver enzymes and clotting tests. Serology was positive for dengue. Because of 
the persistence of fever and laboratory examinations were consistent with hemophagocytic lymphohistiocytosis (HLH) a 
bone marrow aspiration was performed, which confirmed the presence of hemophagocytosis. Hence we report a rare 
presentation of dengue accompanied by self-limited HLH that hopefully evolve to favorable outcome. 
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CASE REPORT
An 8-year-old female patient presented to the 
emergency care with a history of high-grade fever, 
malaise, and headache for the past 8 days, followed 
by abdominal pain and a cutaneous rash. She had 
been treated with penicillin because of a diagnosis 
of streptococcal pharyngitis, but had no relief of 
symptoms. Physical examination disclosed jaundice, 
fever (axillary temperature of 39.2 °C), painful 
hepatosplenomegaly, and a positive Rumpel–Leede 
test.
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Laboratory findings on admission showed a 
normal peripheral blood count; however, a moderate 
atypical lymphocytosis was present. According to 
the epidemiological data and clinical features, the 
diagnosis of dengue was highly considered and 
further investigation revealed the following results: 
albumin = 2.9 g/dL (reference value [RV]: 3-5 g/dL); 
total bilirubin = 4.65 mg/dL (RV: 0.3-1.2 mg/dL) with 
conjugated bilirubin predominance; clotting tests 
represented by prothrombin time with international 
normalized ratio = 1.37 (RV: 1); activated partial 
thromboplastin time ratio = 1.53 (RV: 1); alanine 
aminotransferase = 412 U/L (RV: 34 U/L); and 
aspartate aminotransferase = 975 U/L (RV: 10-49 U/L). 
The abdominal ultrasonography revealed homogenous 
hepatosplenomegaly and a small amount of free liquid 
in the abdominal cavity.
Taking into account the clinical picture and the 
presence of lymphocytic atypia and hepatocellular 
injury, a broad work-up was mandatory, including 
serologies for cytomegalovirus, viral hepatitis types 
A, B, and C, Epstein-Barr virus, and toxoplasmosis, 
which were negative for immunoglobulin G (IgG) 
and immunoglobulin M (IgM) antibodies. Because 
of the persistence of fever, the negative results 
of the aforementioned serologies, and the low 
probability of malignancy, the hypothesis of HLH was 
considered. In this setting the dosage of fibrinogen 
was 105 mg/dL (RV: 175-400 mg/dL); triglycerides was 
664 mg/dL (RV: <100 mg/dL); lactic dehydrogenase 
1536 U/L (RV: 120-246 U/L); ferritin was 16,500 ng/mL 
(RV: 10-291 ng/mL); and bicytopenia ensued (anemia 
and leukopenia). On the nineteenth day of fever, 
the serology results for dengue and yellow fever (YF) 
became available, confirming dengue infection (IgM 
was positive for dengue and negative for YF).
With these results, the hypothesis of HLH was 
strengthened and a myelogram was performed, 
which showed macrophages phagocyting red and 
white blood cells (Figure 1). Therefore, the diagnosis 
Figure 1. A, B, C and D - Photomicrography of the bone marrow aspiration showing histiocytes phagocyting red 
blood cell, precursors and white blood cell characterizing hemophagocytosis.
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of HLH was confirmed based on the Histiocyte Society 
criteria.1 As HLH is a great cause of morbidity and 
mortality, our major concern was the path that the 
disease would follow; however, surprisingly, further 
physical examinations and laboratory tests improved 
progressively. The fever ceased without any specific 
treatment, which demonstrated a rare case of dengue 
that evolved with a self-limited HLH. The patient 
was discharged and periodically followed-up in the 
out-patient clinic without any further complaint.
DISCUSSION
Dengue is a viral self-limited infection with a 
broad spectrum of presentations ranging from classic 
dengue characterized by mild malaise and headache, 
the dengue hemorrhagic fever with increased 
capillary fragility and permeability associated with 
thrombocytopenia and bone marrow suppression,2-4 
to the most severe form: dengue shock syndrome. 
The 2009 revised WHO criteria recommended the 
classification of dengue according to the severity of 
illness in: dengue without warning signs; dengue with 
warning signs (abdominal pain, persistent vomiting, 
fluid accumulation, mucosal bleeding, lethargy, liver 
enlargement, increasing hematocrit with decreasing 
platelets); and severe dengue (dengue with severe 
plasma leakage, severe bleeding, or organ failure).2,5
Although dengue is usually a self-limited disease, 
many complications have been described;2,6,7 among 
them the HLH has been increasingly reported.4-19
It is well known that HLH is associated with various 
infections—mainly viral.20 The syndrome is marked by 
an inflammatory cytokine storm with an overreaction 
of T-cell lymphocytes, which, in turn, activate and then 
recruit monocytes and macrophages, and eventually 
cause hemophagocytosis in the bone marrow, spleen 
and/or lymph nodes (one of the histologic criteria for 
diagnosis). The other criteria are cytopenia (at least two 
lineages), fever, splenomegaly, decreased fibrinogen 
and/or increased triglyceride determinations, low or 
absent natural killer cells activity, increased soluble 
CD25, and a marked increase in the serum ferritin 
levels. At least five of the aforementioned findings 
are required to confirm HLH. Diagnosis is usually 
challenging, as it can be easily mistaken with other 
clinical situations, such as sepsis or other systemic 
inflammatory response syndromes (SIRS).1,18,21
The association of dengue with HLH has been 
frequently reported.3,22 Many similarities involve dengue 
and HLH, such as a marked increase of cytokines 
dosages and thrombocytopenia. The diagnosis 
of dengue associated or not to HLH is somewhat 
challenging since hemophagocytic activity and 
increased determination of ferritin may be present in 
dengue without the development of HLH.1
While most HLH cases associated with dengue 
were observed in secondary and/or dengue with 
warning signs/severe dengue cases,9,16,18 our patient 
had a classic dengue without warning signs and only 
after developing HLH, did she presented liver injury, 
splenomegaly, and sustained bicytopenia. Therefore, 
clinicians should be alert to HLH not only during acute 
dengue infection, but also as a complication after the 
initial 7-day course of dengue infection, especially if 
there is a late onset of jaundice, splenomegaly, central 
nervous system symptoms, and SIRS.
Although HLH is generally a severe disease 
that requires specific and aggressive therapies 
(corticosteroids, etoposide, and cyclosporine A), 
the patient reported herein had a very uncommon 
clinical course. The prognosis of genetic HLH without 
treatment may be very poor, with a median survival 
of up to 2 months21 and a less than 10% likelihood of 
survival for 3 years.1 Therefore, bone marrow aspiration 
should be done, especially if fever persists or relapses 
along with other HLH symptoms and criteria.
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